- Details
- Description
Composition:
Vericiguat
Treatment:
Chronic heart failure with reduced ejection fraction (HFrEF)
Form:
Tablet
Brand:
LuciVeric
Quantity Unit:
Tablets
Manufacturer:
Luci Pharma
LuciVeric (Vericiguat) is a prescription medicine containing vericiguat, a soluble guanylate cyclase (sGC) stimulator. It is used to reduce the risk of cardiovascular death and hospitalization following worsening heart failure in eligible adults with chronic heart failure and reduced ejection fraction. Vericiguat works by stimulating the nitric oxide–sGC–cGMP pathway, which helps improve vascular function and reduce the effects of heart failure. LuciVeric should be taken as prescribed and used under the supervision of a healthcare professional.
